ACTINNO

Act Inno, a subsidiary of Insel Gruppe AG, was established in 2019 by the Department of Cardiology to support cardiovascular translational activities. The company provides extensive expertise in the development and research of medical devices, particularly in the field of cardiology. Act Inno serves clients involved in the early stages of product development through to end-user training, utilizing dedicated test and training facilities. The business operates in the medical device market, focusing on cardiovascular innovations. Act Inno generates revenue by offering specialized workshops and experimental surgical stations that maximize benefits for its customers. The company is led by experts such as Andreas Haeberlin, an electrophysiologist, and Prof. Fabien Praz, an invasive cardiologist, ensuring high-level expertise in complex device interventions and structural heart valve interventions. Act Inno's business model revolves around providing tailored solutions and training to medical professionals and organizations, enhancing the development and application of cardiovascular medical devices.

Keywords: cardiovascular, medical devices, development, research, workshops, training, cardiology, interventions, expertise, facilities.